Skip to main content
Content for healthcare professionals only
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
View all Platforms
Cardiology
Topics
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
Events
Upcoming Events
Radcliffe Events
All Events
Radcliffe Platforms
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
Content for healthcare professionals only
Topics
Featured
Advancement in Heart Failure
Amyloidosis
Cardiomyopathy
Cardio-oncology
Diabetes
Hypertension Management
Nonalcoholic Steatohepatitis (NASH)
Obesity
Pulmonary Embolism
Stroke Prevention in Atrial Fibrillation
Sudden Cardiac Death
Anticoagulation
COVID-19
CV Disease in Special Populations
Demographic
Digital Health
Electrophysiology & Arrhythmia
Heart Failure
Heterogeneous Populations
Imaging & Diagnostics
Intervention
MI / ACS
Pericardium Disorders
Prevention & Chronic Conditions
Standards & Guidelines
Vascular Disease & Surgery
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Juan Carlos Kaski
Peter O'Kane
Ankur Kalra
Angelo Auricchio
Harriette Van Spall
Andrew Coats
Mirvat Alasnag
Arjun Ghosh
Demos Katritsis
Nicolas Van Mieghem
Joost Daemen
Carolyn Lam
Events
Upcoming Events
Radcliffe Events
All Events
Breadcrumb
Home /
News Index
Latest News
Written by:
Veryan Medical
Announcement for Veryan re the US launch of BioMimics 3D
01 September 2020
Written by:
Vasorum and Veryan Medical
Veryan and Vasorum joint press release
10 August 2020
Written by:
Radcliffe Cardiology
[INFOGRAPHIC] A Statistical Comparison of TAVR vs SAVR based on PARTNER Trial Results
07 July 2020
Written by:
Terumo Europe
Major late-breaking Ultimaster DES news from PCR eCourse 2020
29 June 2020
Written by:
BioCardia®
BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19…
29 June 2020
Written by:
Veryan Medical Ltd.
Veryan Medical Press Release: Professor Thomas Zeller presents MIMICS-2 3-yr data
09 June 2020
Written by:
Radcliffe Cardiology
[INFOGRAPHIC] Statistical Overview for the Global Burden of Cardiovascular Diseases
06 June 2020
Written by:
Medtronic plc
Medtronic Resolute ONYX™ Des Receives First and Only One-Month Dapt Indication for High Bleeding Risk…
05 June 2020
Written by:
Radcliffe Cardiology
[INFOGRAPHIC] Key Statistics of the 2020 AHA Annual Update on Congenital Cardiovascular Defects (CCDs)
21 May 2020
Written by:
Siemens Healthineers
Siemens Healthineers Talks: COVID-19 Edition Webcast
13 May 2020
Load More
External news
Written by:
Cardiovascular Business
Anemia may help explain why women are more likely to die during heart bypass surgery
17 April 2024
Written by:
Cardiac Vascular News
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
16 April 2024
Written by:
Cardiac Vascular News
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
16 April 2024
Written by:
Medscape
Chelation Therapy and CV Risk: Why TACT2 Showed No Benefit
16 April 2024
Written by:
Cardiac Vascular News
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
16 April 2024
Written by:
Cardiac Vascular News
Cardiawave appoints Olivier Pierron as its Chief Executive Officer
16 April 2024
Written by:
Cardiac Vascular News
Acticor Biotech will Present the Clinical Results of Its Phase 2/3 ACTISAVE Study in the Treatment of Stroke at ESOC 2024
16 April 2024
Written by:
Cardiac Vascular News
TRIA™ Polymer Surgical Valves Surpass 200 Patient Life Years
16 April 2024
Written by:
Cardiac Vascular News
Caranx Medical announces successful world first robotic assisted transcatheter heart valve implantation in an animal
16 April 2024
Written by:
Cardiac Vascular News
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
16 April 2024
Load More